FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/063806 [Registered on: 07/03/2024] Trial Registered Prospectively
Last Modified On: 22/02/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of 2 drug combinations for sedation in cervical cancer patients undergoing radiotherapy 
Scientific Title of Study   Comparative evaluation of Dexmedetomidine-Ketamine versus Ketamine-Propofol for sedation and analgesia in cervical cancer patients for intra cavitary brachytherapy: A prospective randomized double blind study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sakshi 
Designation  Assistant Professor 
Affiliation  Ananta institute of medical sciences 
Address  Department of anesthesia, OT complex, 2nd floor, Room no. 2041,Ananta institute of medical sciences, Rajsamand Rajsamand RAJASTHAN 313202 India

Rajsamand
RAJASTHAN
313202
India 
Phone  9571241824  
Fax    
Email  drsakshiarora88@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nirdesh Thakore 
Designation  Assistant Professor 
Affiliation  Ananta institute of medical sciences 
Address  Department of anesthesia, OT complex, 2nd floor, Room no. 2041,Ananta institute of medical sciences, Rajsamand Rajsamand RAJASTHAN 313202 India

Rajsamand
RAJASTHAN
313202
India 
Phone  9461347316  
Fax    
Email  drnirdeshthakore87@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nirdesh Thakore 
Designation  Assistant Professor 
Affiliation  Ananta institute of medical sciences 
Address  Department of anesthesia, OT complex, 2nd floor, Room no. 2041,Ananta institute of medical sciences, Rajsamand Rajsamand RAJASTHAN 313202 India

Rajsamand
RAJASTHAN
313202
India 
Phone  9461347316  
Fax    
Email  drnirdeshthakore87@gmail.com  
 
Source of Monetary or Material Support  
Ananta institute of Medical Sciences, Rajasamand RAJASTHAN 
 
Primary Sponsor  
Name  Ananta institute of medical sciences 
Address  NH8, village Kaliwas, Rajsamand, rajasthan 313202 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nirdesh Thakore  Ananta institute of medical sciences and research centre  Ananta institute of Medical Sciences, Department of anesthesia, 2nd floor OT Complex, Room no. 2041, Rajasamand RAJASTHAN
Rajsamand
RAJASTHAN 
9461347316

drnirdeshthakore87@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Ananta Institute of Medical Science and Research Centre Rajsamand 313202, Rajasthan  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  IV Drug combination (Dexket)  Dexmedetomidine 0/5mic per kg and ketamine 1 mg per kg IV over 2 minutes. Hemodynamics were followed every 5 min for 30 min and hourly for 6 hours. 
Comparator Agent  IV drugs for sedation (Ketofol)  Ketamine 1mg per kg and Propofol 1 mg per kg IV over 2 minutes. Hemodynamics were followed every 5 min for 30 min and hourly for 6 hours. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  70.00 Year(s)
Gender  Female 
Details  Patients of cervical cancer scheduled for elective
brachytherapy
Patients aged between 20-70 years
ASA I, II  
 
ExclusionCriteria 
Details  History of cardiovascular diseases e.g. ischaemic heart disease,conduction defects, etc.
History of compromised renal / hepatic / neuronal functions.
Uncontrolled hypertension and Diabetes
Pregnant or lactating women.
History alcohol, substance abuse, chronic use of analgesic and
sedatives, psychiatric disorders
Patients on b blocker or having persistent bradycardia with HR30
min 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Onset and recovery of sedation   Baseline, 1,2,5,7,10,15,20,25 and 30 minutes. 
 
Secondary Outcome  
Outcome  TimePoints 
Intraoperative Haemodynamics (Heart
Rate,Blood Pressure, Spo2, Respiratory rate)
Post op recovery score (Modified Aldrete Score)
Duration of analgesia 
Baseline, 1, 2,5,7,10,15,20,25 & 30 minutes & then hourly for 6 hours. 
 
Target Sample Size   Total Sample Size="46"
Sample Size from India="46" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   15/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Patients will be allocated to one of the following two groups as per randomization:.Group DK( 23): inj dexmedetomidine (0.5 mic/kg) and ketamine (1 mg/kg) and Group KP ( 23) : inj ketamine 1mg/kg and propofol 1 mg/kg diluted to total volume of 10 ml will be given before beginning the procedure over the period of 2 minutes. Time is recorded to achieve RSS
score of 6 that will indicate onset of sedation. Patients are then placed inlithotomy position and procedure is started which consists of dilation of cervical canal and insertion of applicators and adequate vaginal packing. After completion of procedure patient is again made supine and time is recorded till patients achieve RSS 3, and then shifted to post op area and followed for 6 hours post operatively
 
Close